Metabolic Bone Disease and Clinically Related Disorders

Avioli, Louis V.; Krane, Stephen M.

In stock
Regular price 144.250 KD inc. VAT
License
Table of contents
  • Contentsv
  • Contributorsxi
  • Prefacexv
  • Chapter 1. Embryology and Cellular Biology of Bone1
  • I. Embryonic Skeletal Development2
  • II. Limb Development and Pattern Regulation2
  • III. Bone Morphogenetic Proteins and Development4
  • IV. The Role of Parathyroid Hormone-Related Peptide in Development4
  • V. Fibroblast Growth Factors and Skeletal Development4
  • VI. Cells of the Osteoblast Lineage5
  • VII. The Osteoclast9
  • VIII. Cell–Cell Interaction in Bone Remodeling12
  • IX. Colony-Stimulating Factors and Bone13
  • X. The Transforming Growth Factor β Family13
  • XI. Other Growth Factors (FGF, VEGF, PDGF, and HGF)15
  • XII. Cell–Matrix Interactions16
  • References17
  • Chapter 2. The Nature of the Mineral Phase in Bone: Biological and Clinical Implications23
  • I. Biological Functions of the Mineral Phase23
  • II. The General Nature of the Mineral Phase in Bone and the Changes That Occur with Time28
  • III. Postulated Phases Other Than Apatite as the Initial Solid Ca-P Mineral Phase Deposited in Bone29
  • IV. Crystal Size and Shape32
  • V. Recent Studies of the Structure of Bone Apatities and the Applications of These Date to Clinical36
  • References46
  • Chapter 3. Parathyroid Hormone and Parathyroid Hormone–Related Peptide in Calcium Homeostasis, Bon51
  • I. Introduction: Regulators of Mineral Ion Homeostasis52
  • II. Parathyroid Hormone53
  • III. Parathyroid Hormone–Related Peptide67
  • IV. Receptors That Mediate Analogous and Distinct Molecular Actions of PTH and PTHrP73
  • V. Summary: Overall Biological Roles of PTH and PTHrP and Their Cloned Receptors82
  • References83
  • Chapter 4. Calcitonin95
  • I. Nature of Calcitonin96
  • II. Chemistry98
  • III. Biosynthesis99
  • IV. Secretion and Metabolism101
  • V. Actions of Calcitonin102
  • VI. Calcitonin Receptor108
  • VII. Calcitonin in Clinical Medicine113
  • VIII. Summary113
  • References114
  • Chapter 5. Vitamin D Metabolism and Biological Function123
  • I. History of Vitamin D124
  • II. Photobiology of Vitamin D3127
  • III. Intestinal Absorption of Vitamin D131
  • IV. Metabolism of Vitamin D to 25-Hydroxyvitamin D132
  • V. Metabolism of 25-Hydroxyvitamin D to 1,25-Hydroxyvitamin D135
  • VI. Altemative Metabolism of 25-Hydroxyvitamin D and 1,25-Dihydroxyvitamin D139
  • VII. Metabolism of Vitamin D2141
  • VIII. Biological Actions of 1,25(OH)2D142
  • IX. Biological Actions of 1,25(OH)2D in Tissues Regulating Calcium Balance144
  • X. Actions of Vitamin D Metabolites and Analogs in Nonclassical Target Tissues145
  • XI. Assays for Vitamin D and Its Metabolites148
  • XlI. Conclusion155
  • References156
  • Chapter 6. Pathophysiology of Calcium, Phosphate, and Magnesium Absorption165
  • I. Calcium165
  • II. Phosphate183
  • III. Magnesium190
  • References195
  • Chapter 7. Disorders of Phosphate Homeostasis207
  • I. Phosphate Homeostasis207
  • II. Hypophosphatemia216
  • III. Hyperphosphatemia226
  • References230
  • Chapter 8. Bone Biopsies: A Modern Approach237
  • I. Function and Structure of the Skeleton237
  • II. Bone Biopsies244
  • III. Mineralized Bone Histology Techniques247
  • IV. Molecular Bone Histology249
  • V. Evaluation of Bone251
  • VI. Indications For and Information Derived from Bone Biopsies256
  • VII. Information Derived from Molecular Histology268
  • References269
  • Chapter 9. Noninvasive Assessment of Bone275
  • I. Introduction275
  • II. Radiation-Based Assessment of Bone277
  • III. Assessment of Bone without Radiation292
  • IV. Standardization and Quality Assurance in Dual X-Ray Absorptiometry298
  • V. Clinical Applications300
  • References303
  • Chapter 10. Biochemical Markers of Bone Turnover313
  • I. Introduction313
  • II. Bone Matrix, Minerals, and Cells314
  • III. Bone Turnover: Modeling and Remodeling314
  • IV. Biochemistry of Bone Turnover315
  • V. Markers of Bone Formation316
  • VI. Markers of Bone Resorption318
  • VII. 24-Hour Variation in Markers of Bone Turnover321
  • VIII. Potential Use of Biochemical Markers321
  • IX. Conclusions324
  • References324
  • Chapter 11. Osteomalacia and Related Disorders327
  • I. Bone Mineralization and the Mechanisms of Osteoid Accumulation328
  • II. Manifestations of Osteomalacia338
  • III. Etiological Classification and Pathogenesis of Osteomalacia349
  • IV. Osteomalacia Resulting from Abnormal Vitamin D Metabolism354
  • V. Vitamin D and Age-Related Osteoporosis360
  • VI. Osteomalacia Resulting from Abnormal Phosphate Metabolism361
  • VII. Osteomalacia with Normal Vitamin D and Phosphate Metabolism367
  • VIII. Therapeutic Intervention in Osteomalacia370
  • References374
  • Chapter 12. Osteoporosis Pathogenesis and Therapy387
  • I. Definition387
  • II. Physiological Osteoporosis389
  • III. Diagnostic Aids390
  • IV. Classification395
  • V. Management397
  • References406
  • Chapter 13. Primary Hyperparathyroidism411
  • I. Introduction411
  • II. Etiology and Pathology412
  • III. Clinical Features: Changing Clinical Presentation418
  • IV. Diagnosis and Differential Diagnosis426
  • V. Medical Management of Hypercalcemia and Hyperparathyroidism431
  • VI. Summary435
  • References435
  • Chapter 14. Renal Osteodystrophy443
  • I. Introduction443
  • II. Secondary Hyperparathyroidism and Osteitis Fibrosa443
  • III. Osteomalacia451
  • IV. Bone Histology451
  • V. Clinical and Biochemical Features of Altered Divalent–Ion Metabolism453
  • VI. Radiographic Features of Renal Osteodystrophy455
  • VII. Extraskeletal Calcifications456
  • VIII. Therapeutic Approach to Renal Osteodystrophy456
  • References460
  • Chapter 15. Surgical Treatment for Hyperparathyroidism465
  • I. History of Surgery for Hyperparathyroidism465
  • II. Primary Hyperparathyroidism: Preoperative Evaluation466
  • III. Primary Hyperparathyroidism: Conduct of the Operation469
  • IV. Primary Hyperparathyroidism: Management of Patients with Persistent or Recurrent Hyperparathyroi472
  • V. Operative Management of Patients with Parathyroid Carcinoma475
  • VI. Operative Management of Patients with Renal Osteodystrophy475
  • VII. Postoperative Management475
  • References477
  • Chapter 16. Familial Benign Hypocalciuric Hypercalcemia and Other Syndromes of Altered Responsivenes479
  • I. Introduction479
  • II. Syndromes of Extracellular Calcium Resistance480
  • III. Autosomal Dominant Hypocalcemia„A Syndrome of Increased Responsiveness of Target Tissues to C493
  • IV. Summary and Conclusions496
  • References496
  • Chapter 17. Hypoparathyroidism and Pseudohypoparathyroidism501
  • I. Introduction501
  • II. Pathophysiology of Hypocalcemia502
  • III. Signs and Symptoms of Hypocalcemia504
  • IV. Specific Causes of Functional Hypoparathyroidism505
  • V. Pseudohypoparathyroidism510
  • VI. Diagnosis519
  • VII. Treatment521
  • VIII. Conclusion522
  • References522
  • Chapter 18. Bone Disease in Hyperthyroidism531
  • I. Grades of Hyperthyroidism531
  • II. Overt Hyperthyroidism532
  • III. Endogenous Subclinical Hyperthyroidism534
  • IV. Exogenous Subclinical Hyperthyroidism: Thyroid Hormone Suppressive Therapy535
  • V. Thyroid Hormone Replacement Therapy539
  • VI. Treatment and Prevention of Thyroid Hormone–Mediated Bone Loss539
  • VII. Conclusions541
  • References541
  • Chapter 19. Paget's Disease of Bone545
  • I. Historical Aspects545
  • II. Incidence and Epidemiology545
  • III. Histopathology547
  • IV. Focal Manifestations554
  • V. Local Complications562
  • VI. Metabolic Aspects of Paget's Disease569
  • VII. Systemic Complications and Associated Diseases578
  • VIII. Drug Treatment581
  • IX. Surgery592
  • X. Etiology593
  • References596
  • Chapter 20. Sarcoidosis and Related Disorders607
  • I. Granulomatous and Infectious Diseases607
  • II. Lymphoma and Solid Tumors613
  • III. Miscellaneous Diseases614
  • References615
  • Chapter 21. Bone Disease in Rheumatological Disorders621
  • I. Introduction621
  • II. Rheumatoid Arthritis622
  • III. Seronegative Spondyloarthropathies626
  • IV. Systemic Lupus Erythematosus628
  • V. Juvenile Rheumatoid Arthritis628
  • References633
  • Chapter 22. Hypercalcemia of Malignancy637
  • I. Pathophysiology637
  • II. Clinical Features642
  • III. Treatment643
  • References646
  • Chapter 23. Osteogenesis Imperfecta651
  • I. Introduction651
  • II. Perspective: Clinical Introduction651
  • III. Clinical Features657
  • IV. Pathophysiology663
  • V. Collagen Biochemistry and Bone Cell Biology as Related to OI666
  • VI. Biochemical and Molecular Tools for the Identification of Mutations in Patients with OI670
  • VII. Molecular Pathophysiology of OI673
  • VIII. Therapy678
  • IX. Future Diagnostic and Therapeutic Directions681
  • References683
  • Chapter 24. Skeletal Disorders Characterized by Osteosclerosis or Hyperostosis697
  • I. Introduction697
  • II. Osteopetrosis698
  • III. Carbonic Anhydrase II Deficiency703
  • IV. Pycnodysostosis705
  • V. Osteomesopyknosis707
  • VI. Progressive Diaphyseal Dysplasia (Camurati- Engelmann Disease)707
  • VII. Endosteal Hyperostosis710
  • VIII. Osteopoikilosis713
  • IX. Osteopathia Striata715
  • X. Melorheostosis716
  • XI. Mixed Sclerosing Bone Dystrophy718
  • XII. Fibrodysplasia Ossificans Progressiva719
  • XIII. Axial Osteomalacia722
  • XIV. Fibrogenesis Imperfecta Ossium726
  • XV. Fluorosis728
  • XVI. Pachydermoperiostosis729
  • XVII. Hepatitis C–Associated Osteosclerosis731
  • XVIII. Other Disorders731
  • References732
  • Chapter 25. Kidney Stones: Pathogenesis, Diagnosis, and Therapy739
  • I. Introduction739
  • II. Hypercalciuria740
  • III. Hyperuricosuria747
  • IV. Hyperoxaluria748
  • V. Hypocitraturia750
  • VI. Gouty Diathesis752
  • VII. Cystinuria753
  • VIII. Infection with Urea-Splitting Organisms755
  • IX. Conservative Management755
  • References756
  • Chapter 26. Metabolic Bone Disease in Children759
  • I. Introduction759
  • II. Skeletal Development759
  • III. Rickets and Osteomalacia764
  • References777
  • Index785
  • Color Plate SectionColor Plate-1
Book details
  • Vendor Elsevier S & T
  • SKU 9780120687008
  • ISBN-13 9780080536279
  • Author Avioli, Louis V.; Krane, Stephen M.
  • Edition 3rd
  • Category Medical
  • Subject Orthopedics

Do you have questions about this book?

Ask an expert!

Metabolic Bone Disease, Third Edition is the new, expanded edition of the classic text, featuring the latest advancements and research information in this fast-moving field. The Third Edition includes the most up-to-date information on molecular mechanisms, basic biology, pathophysiology, and diagnosis and management strategies of metabolic bone disease.

Key Features
* Edited by "fathers of the field"
* An expanded version of a classic AP text
* Complete coverage of a fast-growing field